Four Tests, One Result

We offer four state-of-the-art tests: Molecular Identification, Molecular Antibiotic Gene Resistance, Antibiotic Sensitivity Testing, iQ Ab Guide

Industry Leading Testing

iQ Genetix Testing Capabilities


Molecular UTI With Antibiotic Gene Resistance And Antibiotic Sensitivity Combined With the iQ Genetix Intelligent Antibiotic Reference Guide

Respiratory Pathogen Panel

Rapid identification of respiratory pathogens and Coronavirus utilizing Quantitative Real-Time PCR Technology.


Molecular STI With Antibiotic Gene Resistance And Antibiotic Sensitivity With the iQ Genetix Intelligent Antibiotic Reference Guide

Gastrointestinal Pathogen Panel

Real-time PCR analyzes your patient's sample, identifies bacterial, viral, and parasitic pathogens & detects antibiotic drug resistant genes.


A sensitive molecular test that targets the detection of the SARS-CoV-2 genes and provide info as to which patients are infected.

Wound Pathogen Panel

Rapid pathogen identification using RT-PCR for wound management to detect polymicrobial organisms and antibiotic resistance.

Our Testing

Molecular UTI Panel

Urinary tract infections are among the most common types of illnesses among all ages. Each year, around 150 million people are affected by symptomatic or asymptomatic urinary tract infections, which could present serious health issues.

Molecular uti

What Seperates Our Tests

Currently, UTIs are diagnosed by clinical symptoms, urine analysis and bacterial culture, and are often treated with broad spectrum antibiotics. However, the urinary tract hosts a diverse and complex microbial community, and some of those organisms can be difficult to culture. Emerging evidence shows that urinary tract microbiota may exert profound effects on urinary tract health, both positive and negative. Traditional culture-based or microscopy- based methods for investigation of urinary tract microbiota can lack sensitivity and specificity; they can also be subjective, time-consuming, and inaccurate.

Real-time PCR can detect slow-growing or difficult- to-cultivate microorganisms and can be used when traditional microbiological techniques lead to ambiguous results. Utilizing real-time PCR techniques along with simultaneous testing of antibiotic resistance genes covering multiple drug classes, the latest Antibiotic Sensitivity technology and the most comprehensive intelligent antibiotic treatment database ensures accurate detection and categorization of microorganisms involved in urinary tract microbiome composition and dynamics. With this knowledge, appropriate courses of action can be designed.

  • Increased Accuracy
  • Detection of polymicrobial infections
  • Same day to 48-hour identification of organisms, gene resistance and antibiotic sensitivity
  • Identification of infection causing organism while on medication
  • Reduced hospitalizations
  • Integration of iQ Genetix’s Intelligent Antibiotic Guide
iQ Genetix

Interactive Antibiotic Guide for Molecular UTI Panel

We discover, develop, and market a transformative molecular diagnostic test that addresses pressing clinical needs across multiple medical specialties. Using state-of-the-art analytical equipment, automated specimen processing and advanced reporting applications.

Young female scientist working with microscope in laboratory
Intellegient Diagnostic Solutions

Introducing intelligent diagnostic solutions for antibiotic stewardship in partnership with the Sanford Guide. Antibiotic Stewardship involves making responsible decisions on when and how to prescribe antibiotic therapy.

Accurate Results

The CDC has stated that at least 30% of antibiotics prescribed in the US are either unnecessary or inappropriate. The other 70% is still in need of further customization in choosing the appropriate dosing due to the variability in metabolization and drug absorption.

Antibiotic Guide​

Integrated into an Antibiotic Stewardship program is the perfect solution in helping clinicians quickly decide:

Viral vs. Bacterial Etiology
Pathogen Load Testing
Antibiotic Resistance
Appropriate Antibiotic Guidance

An intelligent molecular based diagnostic solution that is routinely updated with the latest molecular and antibiotic information. This is a unique, data-driven approach that combines precise, molecular pathogen and resistance gene detection with sensitivity and susceptibility data (Sanford Guide®).

Supports clinicians in providing a more targeted and customized treatment plan through pharmacy guidance for their patients within 24 hours of the patient sample arriving at our lab. This guidance may consider the patient’s age, comorbidities, allergies, concomitant medications, regional susceptibility patterns in addition to the test results.

Our Testing

Molecular STI Panel

Sexually transmitted infections are diseases caused by microorganisms and viral infections that spread through sexual contact. When diagnosed in the early stages, many STIs can be easily treated and cured. STIs that remain undiagnosed or untreated can have serious health consequences. Individuals who are asymptotic are still at risk of long-term complications and can still spread the infection. For these reasons, it is important every sexually active individual be screened for STIs.

Chlamydia trachomatis and Neisseria gonorrhea are the two most common sexually transmitted infections. Currently, testing relies on culture, which takes at least 48 hours.

Current STI testing relies on lab culture to identify infections and any drug resistance. This takes at least 48 hours. In the meantime, the patient is prescribed a first-line antibiotic treatment. Pathogens resistant to these antibiotics can result in an ineffective first treatment.

Untreated or inappropriately treated STIs can lead to a range of secondary complications including pelvic inflammatory disease, infertility, complications in pregnancy, reproductive system cancers,
the enhanced transmission of HIV, and epididymitis. The emergence of drug-resistant strains of STI such as gonorrhea is also causing considerable global concern.

Doctor desk with documents and stethoscope


Up to 52% of women will be over-diagnosed with a UTI when visiting emergency departments with traditional UTI symptoms

Doctor explaining diagnosis to her female patient


Up to 50% of women diagnosed with a UTI will have a positive culture and 10-50% will have a STI

Stethoscope on keyboard


Over 37% of women will be underdiagnosed with an STI when visiting emergency departments with traditional UTI symptoms

Our Testing


PCR Tests

PCR tests are the “Gold Standard” for COVID-19 testing. They are sensitive molecular tests that target the detection of the SARS-CoV-2 genes and provide information as to which patients are currently infected.

The iQ Genetix Test

The iQ Genetix RT-PCR based SARS-CoV-2 test detects active COVID-19 infection with simple collection, reliable results, and same day turnaround once the sample is received by the lab.

Female scientist
Our Testing

Respiratory Pathogen Panel

The Respiratory Pathogen Panel quickly detects and differentiates viral and bacterial pathogens so effective treatment can begin sooner

The Respiratory Pathogen Panel utilizes quantitative Real-Time PCR to analyze your patient’s nasal sample and reports results in the same to 24 hours. The test precisely identifies 16 respiratory viruses and bacterial species, including Coronavirus from a single specimen.  Same day to 24-hour turnaround time, preventing delays in diagnosis and treatment

Our Testing

Gastrointestinal Pathogen Panel

Clinical Utility of molecular diagnostic testing is recognized by the American College of Gastroenterology:

“Several well-designed studies show that molecular testing now surpasses all other approaches for the routine diagnosis of diarrhea. Molecular diagnostic tests can provide a more comprehensive assessment of disease etiology by increasing the diagnostic yield compared with conventional diagnostic tests. They are also faster, providing results in hours rather than days.”

Genetic testing is a proven valuable tool for physicians caring for individuals with severe symptoms, have weakened immune system and/or those with advanced age.

Stool cultures have been the standard diagnostic tool for determining the microbial etiology of suspected bacterial infectious diarrhea, however, they are time consuming and have low positive.

Multiplex molecular testing has emerged as valid, fast and accurate diagnostic tool for acute infectious gastroenteritis.

iQ Genetix Gastrointestinal Pathogen Panel quickly identifies enteropathogenic viruses, bacteria, and parasites responsible for gastroenteritis. It simultaneously detects antibiotic resistance genes without risk of false negatives, so effective treatment can begin sooner. The panel utilizes a multiplex quantitative Real-Time PCR approach to rapidly analyze your patient’s sample. It precisely detects the pathogens during single or coinfections and identifies antibiotic drug resistance in one single test versus multiple tests. Test results allow providers to prescribe timely and effective anti-infective medications. It also facilitates antibiotic stewardship by pinpointing situations for which antibiotics should be avoided.

  • Identifies polymicrobial infections
  • Quick clinical decision
  • More accurate the culture
  • Reduces false negatives
  • Not affected by antibiotic use
  • Antibiotic gene resistance identification
  • Reduces unnecessary antibiotic use
  • Helps avoid unnecessary hospitalization
Our Testing

Wound Pathogen Panel

Wound management can be complicated due to polymicrobial organisms and antibiotic resistance.

Multi-layered microbial communities, known as biofilms, surrounded by a self-produced protective extracellular slime further complicate a diagnosis.  More fastidious organisms may not be identified with standard culture, resulting in a delay in the appropriate treatment.

Additionally, the acquisition or emergence of resistance among bacteria that infect or colonize these wounds is a major health concern according to the CDC and the World Health Organization.

iQ Genetix Molecular Diagnostic Test

Leverages RT-PCR technology which precisely identifies pathogens enabling providers to prescribe early effective treatments, while preserving antibiotics effectiveness

Molecular Methods Are Advancing

It's now possible to use bacterial DNA from the wound site to identify the pathogens present. Our Wound Pathogen Panel rapidly establishes the microbiological profile of a sample and simultaneously reveals antibiotic resistance genes.